ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,461, issued on Feb. 18, was assigned to Micreos Pharmaceuticals AG (Baar, Switzerland).
"Chimeric endolysin polypeptide, cluster 3b" was invented by Fritz Eichenseher (Baar, Germany), Mathias Schmelcher (Baar, Germany) and Christian Alexander Rohrig (Baar, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of antibacterial polypeptides, specifically to the field of antibacterial polypeptides having lytic activity for Staphylococcus. The invention relates to a novel chimeric endolysin polypeptide specifically targeting a Staphylococcus cell. The invention further relates to the use of said chimeric endolysin pol...